Tag Archives: FDA approves new malaria vaccine

Mimi Delese Darko, FDA Boss   The Food and Drugs Authority (FDA) has approved R21, a new malaria vaccine, from the Oxford University for use in children between five months to three years.   This makes Ghana the first country in the world to approve the vaccine, which has been …

Read More »